A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

Clinical trial NCT00728091 · TERMINATED

Trial details

NCT number: NCT00728091
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyponatremia Inappropriate ADH Syndrome

Start date: 2008-07-01
Primary completion: 2008-12-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.